B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus–associated acute liver failure
暂无分享,去创建一个
R. Simon | R. Purcell | S. Pittaluga | D. Boon | M. Haas | P. Farci | S. Govindarajan | R. Engle | F. Zamboni | G. Diaz | A. Tice | Zhao-chun Chen | L. Agulto | Cl Yu
[1] R. White,et al. High-Throughput Sequencing of the Zebrafish Antibody Repertoire , 2009, Science.
[2] H. Aghajanian,et al. Negative Regulation of TCR Signaling by Linker for Activation of X Cells via Phosphotyrosine-Dependent and -Independent Mechanisms1 , 2008, The Journal of Immunology.
[3] E. Pai,et al. Germline V‐genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus , 2008, The EMBO journal.
[4] J. Koskinas,et al. Aetiology and outcome of acute hepatic failure in Greece: experience of two academic hospital centres , 2008, Liver international : official journal of the International Association for the Study of the Liver.
[5] L. Meyaard. The inhibitory collagen receptor LAIR‐1 (CD305) , 2008, Journal of leukocyte biology.
[6] M. L. de la Mata,et al. Acute liver failure in Spain: Analysis of 267 cases , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[7] M. Kurrer,et al. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation. , 2006, The Journal of clinical investigation.
[8] K. Boudjema,et al. C4d: a marker for hepatic transplant rejection. , 2006, Transplantation proceedings.
[9] Wei Zhang,et al. Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function , 2006, European journal of immunology.
[10] M. Haas,et al. Antibody-mediated rejection in renal allografts: lessons from pathology. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[11] J. Madrenas,et al. A molecular perspective of CTLA-4 function. , 2006, Annual review of immunology.
[12] A. Chan,et al. B cell immunobiology in disease: evolving concepts from the clinic. , 2006, Annual review of immunology.
[13] R. Fontana,et al. Clinical outcome and virological characteristics of hepatitis B‐related acute liver failure in the United States , 2005, Journal of viral hepatitis.
[14] Eric Vivier,et al. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future , 2004, Nature Reviews Immunology.
[15] G. Zhu,et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. , 2003, Immunity.
[16] R. Purcell,et al. CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection , 2003, Journal of Virology.
[17] A. Pandey,et al. Src-like Adaptor Protein (Slap) Is a Negative Regulator of T Cell Receptor Signaling , 2000, The Journal of experimental medicine.
[18] M. Brunetto,et al. Hepatitis B Virus Mutants , 1999, Intervirology.
[19] H. Okamoto,et al. Hepatitis B Virus Strains with Mutations in the Core Promoter in Patients with Fulminant Hepatitis , 1995, Annals of Internal Medicine.
[20] Takafumi Saito,et al. Electron microscopic study of hepatitis B virus-associated antigens on the infected liver cell membrane in relation to analysis of immune target antigens in chronic hepatitis B , 1992, Gastroenterologia Japonica.
[21] J. Wands,et al. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. , 1991, The New England journal of medicine.
[22] R. Zinkernagel,et al. Production of random classes of immunoglobulins in brain tissue during persistent viral infection paralleled by secretion of interleukin-6 (IL-6) but not IL-4, IL-5, and gamma interferon , 1991, Journal of virology.
[23] D. Moskophidis,et al. Antiviral antibody-producing cells in parenchymatous organs during persistent virus infection , 1987, The Journal of experimental medicine.
[24] D. Milich,et al. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. , 1986, Science.
[25] A. Gimson,et al. Serological markers in fulminant hepatitis B. , 1983, Gut.
[26] A. Alberti,et al. Core antigen-specific immunoglobulin G bound to the liver cell membrane in chronic hepatitis B , 1982 .
[27] A. Eddleston,et al. Defective opsonisation and complement deficiency in serum from patients with fulminant hepatic failure. , 1980, Gut.
[28] L. Bianchi,et al. Evidence for phasic sequences in nuclear HBcAg formation and cell membrane-directed flow of core particles in chronic hepatitis B. , 1977, Gastroenterology.
[29] J. Hoofnagle,et al. Immune response in fulminant viral hepatitis, type B. , 1976, Gastroenterology.
[30] J. Motin,et al. Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance. , 1976, Gut.
[31] R. Purcell,et al. Genomic analysis of the host response to hepatitis B virus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[32] K. Böker,et al. Akutes Leberversagen , 2001, Der Internist.
[33] C. Chu,et al. Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis. , 1987, Gastroenterology.
[34] C. Chu,et al. Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection , 1987 .
[35] A. Alberti,et al. Core antigen-specific immunoglobulin G bound to the liver cell membrane in chronic hepatitis B. , 1982, Gastroenterology.